Solaiman Shereen
SEC CIK 1472827 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | CHRO | 273.6K | — | — | 9 | 2023-03-01 | 2026-03-13 |
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
| 17 | Solaiman Shereen | CHRO | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-16 | 2026-03-13+ | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | F - Tax | $4.66 | -14.7K | 273.6K | -5% | -$68.4K |
| 2026-03-16 | 2026-03-12 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | A - Grant | $0.00 | +173.2K | 282.5K | +158% | $0 | |
| 2026-03-02 | 2026-03-01 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | F - Tax | $4.61 | -1,675 | 109.3K | -2% | -$7,722 | |
| 2025-03-17 | 2025-03-14 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | F - Tax | $10.07 | -6,060 | 111.0K | -5% | -$61.0K | |
| 2025-03-17 | 2025-03-13 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | A - Grant | $0.00 | +63.1K | 117.0K | +117% | $0 | |
| 2025-03-03 | 2025-03-01 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | F - Tax | $10.73 | -1,912 | 53.9K | -3% | -$20.5K | |
| 2024-03-18 | 2024-03-14 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | A - Grant | $0.00 | +41.0K | 55.8K | +278% | $0 | |
| 2024-03-04 | 2024-03-01 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | F - Tax | $22.18 | -1,108 | 14.7K | -7% | -$24.6K | |
| 2023-03-02 | 2023-03-01 | MYGN | MYRIAD GENETICS INC | Solaiman Shereen | CHRO | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations